Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Nifty Pharma index tanks over 3% on Trump’s 25% tariff threat; Aurobindo Pharma top loser
Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 19, after U.S. President Donald Trump announced that he would impose
Markets open flat amid US tariff concerns; Pharma stocks tumble on Trump’s 25% tax threat
Equity markets opened on a tepid note Wednesday morning as concerns over potential US tariffs weighed on investor sentiment despite positive global cues. The benchmark
Aurobindo Pharma arm’s facility receives 5 observations from USFDA
The United States Food and Drug Administration (US FDA) conducted a pre-approval inspection at Eugia Steriles, a 100 per cent subsidiary of Eugia Pharma Specialities and
HAL, NBCC , Gillette India, Bharat Forge, Natco Pharma share price in focus as will trade Ex-Dividend today
Dividend Stocks 2025: Hindustan Aeronautics Ltd, NBCC (India) Ltd, Gillette India Ltd, Bharat Forge and NATCO Pharma share prices will remain in focus on Tuesday
India should seek key concessions from US to boost pharma exports: Pharma industry
In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA) and Indian Drug Manufacturers Association (IDMA) want India to
Stock market today: Nifty 50, Sensex recover smartly from day’s low, snap 8-day losing run; pharma stocks top gainers
After an 8-day consecutive decline on Dalal Street, bulls finally took charge during Monday’s trading session on February 17, pushing the front-line indices into positive
Aurobindo Pharma to commence supplies to Europe from China plant in April
Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker
Natco Pharma: Looming Gap in Earnings
Natco Pharma corrected a significant 32 per cent last week. The stock declined 20 per cent on Thursday and further corrected 9 per cent on
Glenmark Pharma clocks Q3 PAT of ₹348 crore
Drugmaker Glenmark Pharmaceuticals clocked a consolidated revenue of ₹3,387 crore for the three months ended December 31, 2024, up 35 per cent from ₹2,506 crore
Drugmakers hope for efficiencies, as new US Health Secretary RFK aims to stick with the science
As the 26th Secretary of the US Department of Health and Human Services (HHS), Robert F Kennedy Jr takes charge of institutions including the United States